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Methods: e-MISAGO enrolled more than 3000 patients treated with the Misago stent in
94 European centers. All clinical data collected through an EDC platform are fully
monitored and all reported serious adverse events are independently adjudicated. Primary
safety (at 30 days) and efficacy endpoint (at 1 year) match the VIVA criteria.
Results: Patients (68% male) were 6710 years old, 63% were smokers, 36% had
diabetes mellitus (36% IDDM), 46% had hypercholesterolemia and 76% arterial hyper-
tension. Patients had history of previous coronary artery disease in 32% of the cases and
14% previous myocardial infarction. Claudication and symptomatic ischemia concerned
99% and 96% of the patient population. Mean lesion length was 64.559.0 mm, with
reference vessel diameter 6.31.3 mm. Mean lesions’ stenosis was 88.612.4% and
43.3% of the lesions were totally occluded. On average 1.20.5 vessels per patient were
treated with 1.20.45 stents per lesion. At baseline mean ABI was 0.590.22 and mean
Rutherford score was 2.511.31. At 12 months ABI improved in 81% patients and the
mean increased to 0.850.24; Rutherford score improved in 76% patients with mean
value of 0.721.16. The overall composite adverse events rate of death, amputation, and
revascularization was 9.7%.
Conclusions: The interim results from the e-MISAGO registry indicate promising device
performance of the Misago RX nitinol stent at 1 year.
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Background: The impact of vascular injury on drug transfer and vessel healing
following Paclitaxel Coated Balloon (PCB) use has not been described. We hypothesized
that the vessel uptake of paclitaxel and its resulting effect on healing is highly influenced
by the degree of mechanical injury exerted to the vessel wall following balloon inflation.
Methods: A total of 19 PCB (Cotavance, Medrad, Inc. Indianola, PA) were inflated in the
iliofemoral territory of 8 domestic swine targeting a 1.2:1 balloon to artery ratio (BAR).
All arteries were harvested at either 14 (n9) or 30 (n10) days for the evaluation of
tissue paclitaxel levels and histology. Based on the histological injury scores, all vessel
segments were classified into IEL ruptured (IEL-R) or IEL non-ruptured (IEL-NR).
Results: A total of 19 iliofemoral arteries were included in the analysis. The IEL-R group
had a higher BAR (1.440.08) compared to the IEL-NR (1.340.11, p0.1). At 14 days,
the median concentration of paclitaxel in the IEL-R group (1,251g/g) was higher than in
the IEL-NR group (465 g/g, p0.13). However, the% area of stenosis was comparable
among both groups at 14 and 30 days (see table). At 30 days, Paclitaxel tissue levels were
comparable among both groups. Fibrin and inflammatory scores were consistently higher
in the IEL-R group compared to the IEL-NR group at both 14 and 30 days (see table).
Conclusions: The degree of mechanical injury induced by balloon dilatation seems to
influence short-term drug transfer and long-term vessel healing following PCB use. The
implications of these findings on clinical outcomes deserve further evaluation in the
human setting.
Follow
Up
IEL
Rupture
Balloon
to Artery
Ratio
Fibrin
Score
Mean
Inflammation
Score
Area
Stenosis
(%)
Median
Concentration
(g/g)
15
Days
Yes 1.44 
0.08
3.00 
0
1.25  0.5 5.34 
1.39
1251.00
No 1.34 
0.11
1.74 
1.15
0.74  0.45 5.78 
5.25
465.00
p value 0.10 0.001 0.13 0.75 0.13
30
Days
Yes 1.61 
0.26
1.78 
0.83
1.00  0.5 11.43 
4.46
79.60
No 1.39 
0.25
1.07 
1.27
0.67  0.49 16.71 
10.45
66.50
p value 0.06 0.11 0.13 0.10 0.06
TCT-171
Paclitaxel Balloon Delivery Results In Homogeneous In-Stent Neointimal
Distribution and Reduction of Stent Edge Stenosis Progression in the
Peripheral Swine Model
Maxwell Afari1, Armando Tellez1, Seung-Jin Oh2, Piotr Buszman1,
Yanping Cheng1, Jong Shiuan Yeh1, Gerard Conditt1, Greg Kaluza1,
Juan Granada3
1Cardiovascular Research Foundation, Orangeburg, NY, 2Jack H. Skirball Center
for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg,
NY, 3CRF, Orangeburg, USA
Background: Due to the mechanism of drug transfer, Paclitaxel coated balloons (PCB)
are thought to result in non-uniform inhibition of neointima. We sought to investigate the
pattern of neointima distribution along the stented and reference(edges) segments
following PCB dilatation as compared to POBA controls in a peripheral swine model.
Methods: 16 Iliofemoral arteries were injured with balloon overstretch followed by a
BMS deployment. At 14 days, the in-stent restenosis was treated with either a PCB
(Cotavance, Medrad Inc, PA) or an identical uncoated balloon (POBA). At 28 days
following balloon inflation, all segments were analyzed by QVA and OCT. The OCT
percent area stenosis (%AS) was analyzed every 2mm along the treated segment. Percent
diameter stenosis (%DS) was analyzed within 5mm proximal and distal to the stent
marker by QVA.
Results: The efficacy of PCB was demonstrated by the 43% reduction of%AS by OCT
(27.39% versus POBA: 4713%, p0.006). In the test for homogeneity of variances,
there was no significant longitudinal variation between segments treated with PCB
(p0.2) or POBA (p0.6, see figure). At follow up, POBA demonstrated a progression
in neointimal proliferation at distal (26.9% increase, p0.001) and proximal (8.0%
increase, p0.05) vessel reference segments. Conversely, PCB exhibited neointimal
regression in the distal (-7.7%, p0.05) and proximal (1.4%, p0.5) reference segments.
Conclusions: In vivo OCT analysis showed a homogeneous inhibition of neointimal
formation following paclitaxel delivery. In addition the use of PCB reduces neointimal
proliferation at the borders of the stent.
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Background: Drug-coated balloons (DCB) have emerged as a potential alternative in
treating PAD. This study aimed to evaluate the tissue concentrations and efficacy of using
the Freeway DCB in porcine peripheral arteries. Thus no further extrapolation from
coronary preclinical experiments is needed.
Methods: Measurements of tissue paclitaxel concentration at 1h, 1 day, 3 days and 9 days
after dilation of peripheral arteries with Freeway™ balloon (Paclitaxel-eluting DEB) for
1 or 2 min in a total of 92 porcine arteries. Inflation time dependent determination of the
paclitaxcel concentration in the blood plasma Inflation time dependent determination of
the remnant paclitaxel concentration on the inflated balloon Histological investigations in
a porcine post-overstretch injury (1.3:1 balloon/artery ratio) model after 2 min inflation of
Freeeway™ (Paclitaxel-eluting DEB) or conventional balloon Measurement of area
stenosis (%) Measurement of neointimal area (mm2)
Results: Tissue Ptx concentrations: 1 hour post 238  molar at 1 min, 502  molar at 2
min of inflation 1 day post 26  molar at 1 min, 129  molar at 2 min 3 days post 19 
molar at 1 min, 35  molar at 2 min 9 days post 4  molar at 1 min and, (still to come)
at 2 min Plasma concentrations: 1 hour post 0,6 ng/ml at 1 min, 2,3 ng/ml at 2 min
Remnant Paclitaxel on the balloon 28% after 1 min,19% after 2 min Post-overstretch
injury (1.3:1): Femoralis neointima area of 0,62 mm2 for DCB vs 1,51 mm2 for POBA
p0.05 Iliaca 0,62 mm2 for DCB vs 1,24 mm2 for POBA p0.05 Area stenosis:
Femoralis 12,5% for DCB vs. 35,9% for POBA p0.05 Iliaca 16% for DCB vs. 32,3%
for POBA p0.05
Conclusions: The new dataset for peripheral arteries from porcine preclinical experi-
ments shows paclitaxel tissue concentration comparable to coronary results one hour post
inflation after 1 minute of inflation of the DCB. After 2 minutes, the concentration in
tissue was approx. double. This effect holds true for later time points up to 9 days. Safety
has been established in plasma measurements, and efficacy was significant in both
Femoralis and Iliaca as compared to POBA after balloon overstretch.
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